The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (α-MSH) therapy
- 2 January 2008
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 22 (5) , 639-646
- https://doi.org/10.1016/j.bbi.2007.11.001
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A Comparative Study of the Central Effects of Specific Proopiomelancortin (POMC)-Derived Melanocortin Peptides on Food Intake and Body Weight in Pomc Null MiceEndocrinology, 2006
- Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune diseaseThe Journal of Experimental Medicine, 2006
- α-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA DamageJournal of Biological Chemistry, 2005
- Melanocortins in fibroblast biology – current update and future perspective for dermatologyExperimental Dermatology, 2004
- Single injection of naked plasmid encoding α-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in miceBiochemical and Biophysical Research Communications, 2004
- α‐Melanocyte‐stimulating hormone induces cell death in mast cells: involvement of NF‐κBFEBS Letters, 2003
- Neuropeptide Regulation of Immunity: The Immunosuppressive Activity of Alpha‐Melanocyte‐Stimulating Hormone (α‐MSH)Annals of the New York Academy of Sciences, 2000
- Anti-inflammatory actions of the neuroimmunomodulator α-MSHImmunology Today, 1997
- Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet BBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Inhibits Experimental Arthritis in RatsNeuroimmunomodulation, 1994